LEADSCOPE, INC. — Department of Health and Human Services SBIR Phase I: NIEHS
LEADSCOPE, INC. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $149,460
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- NIEHS
- Solicitation
- PA15-269
- NAICS
- —
- Place of performance
- OH
- Period
- 2016-06-01 → 2017-08-31
Description
DESCRIPTION provided by applicant In many situations it is critical to rapidly estimate the safety of new or existing chemicals For example in the event of a sudden unexpected exposure of a chemical such as with a chemical spill or a terrorist attack an emergency response is needed to determine if and how to mitigate any potential risk from the chemicalsandapos toxicity and to monitor this risk over time To support chemical research and development toxicity estimates are needed to ensure compounds are prioritized to minimize safety concerns In these cases it is not possible to generate traditional in vivo or even in vitro safety studies ue to the time needed to perform the experiments and interpret the data as well as the cost associated with performing these tests The only viable approach for generating this safety assessment is to use computational approaches that retrieve any existing historical data and in the absence of data calculate a prediction These computational or in silico tools are becoming increasingly relied upon in product design and for product prioritization yet they are not routinely used in regulatory decisions or emergency response situations This situation is now changing through the introduction of a regulatory guideline that permits the use of in silico tools for prediction of bacterial mutagenicity of pharmaceutical impurities the ICH M guidance The development of an appropriate guideline along with supporting standard operating procedures SOPs has been instrumental in the adoption of in silico tools in this area In this phase I proposal two SOPs will be generated to support the evaluation of genetic toxicity and acute toxicity They will outline how to use and interpret available data generate predictions based on Q SAR methodologies and read across approaches how to appropriately interpret prediction results assess a confidence level for the results and define the contents of an accompanying expert opinion These SOPs will be created and then published in peer reviewed publications by a working group of interested parties Using the principles and procedures outlined in these SOPs a single software application will be developed to rapidly identify data generate toxicity predictions assess prediction confidence and make recommendations on exposure thresholds New in silico methods will be developed including Q SAR models to predict GHS Globally Harmonized System of Classification and Labelling of Chemicals classifications for acute toxicity as well methods for prediction of mutagenicity and clastogenicity In phase II several new SOPs will be generated to cover the use and interpretation of in silico approaches for all common toxic effects necessary for a complete safety assessment Existing and newly developed models will be incorporated into to platform This tool will be commercialized and licensed as an application to support the rapid response to safety questions including emergency response situations and product design PUBLIC HEALTH RELEVANCE This project is focused on the computational hazard identification of chemicals with the aim to improve environmental public health and prevent disease by addressing the backlog of thousands of untested chemicals